Senior Director, Business Development at evitria
Mail: rp@evitria.com
Starting at evitria in 2020 as Director of Client Relations, Richard Park has been Senior Director, Business Development at Evitria since 2024. This makes him the interface between clients and the company, specialized in providing service solutions for expression and purification in the antibody production.
Richard Park graduated from Brown University with Bachelor’s degrees in French studies and biomedical engineering, the latter of which he concluded with a thesis on the “Dilutive effects of protein-SDS complexes in microfluidic gel electrophoresis”. Consequently, he has gained broad experience in the biotechnology industry as well as being concerned with civil rights and social actions.
LinkedIn profile: Richard Park
Articles
HEK cells are a popular instrument in medicine and research. In this article, we will provide an overview of this fascinating cell type, from its history to current applications and alternatives.
Recombinant protein expression is an essential component in several scientific and biomedical processes. This is why, in this article, we will take a general look at recombinant protein production.
In this Webinar, Richard Park from evitria, will present Case Studies on Flexibility: Bespoke Solutions for Lead Selection & Optimization in Cancer Antibody Research – get your video now!